{
    "nct_id": "NCT03127956",
    "official_title": "An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris",
    "inclusion_criteria": "* Signed informed consent or assent (for subjects under legal adult age)\n* Completed Week 12 visit of either DRM01B-ACN03 or DRM01B-ACN04 studies.\n* Willing to comply with the protocol. Subjects under legal adult age will be assessed by the investigator as to their ability to comply with the protocol\n* Willing to refrain from using any treatments on the face for acne vulgaris, other than the investigational product, including topical or systemic antibiotics.\nHealthy volunteers allowed\nMust have minimum age of 9 Years",
    "exclusion_criteria": "* Abnormal clinically significant findings on physical exam, vital signs or ECG at Week 12 visit of either the DRM01-ACN03 or DMR01-ACN04 studies that would make further treatment with Olumacostat Glasaretil Gel contraindicated, as determined by the Investigator\n* Any other condition which, in the judgment of the investigator, would put the subject at unacceptable risk for participation in the study",
    "miscellaneous_criteria": ""
}